Rebound erythema and burning sensation from a new topical brimonidine tartrate gel 0.33%

J Am Acad Dermatol. 2014 Feb;70(2):e37-8. doi: 10.1016/j.jaad.2013.10.054.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Cutaneous
  • Adult
  • Brimonidine Tartrate
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Erythema / chemically induced*
  • Erythema / physiopathology
  • Female
  • Follow-Up Studies
  • Gels / therapeutic use
  • Humans
  • Pain / chemically induced*
  • Quinoxalines / adverse effects*
  • Quinoxalines / therapeutic use
  • Recurrence
  • Risk Assessment
  • Rosacea / diagnosis
  • Rosacea / drug therapy*
  • Sampling Studies
  • Severity of Illness Index

Substances

  • Gels
  • Quinoxalines
  • Brimonidine Tartrate